Synopsis of recent research by authors named "Ze-Hui Kok"
- Ze-Hui Kok's research primarily investigates the mechanisms through which natural and pharmacological agents can enhance the efficacy of existing cancer treatments, particularly in the context of chronic myeloid leukemia (CML) and other malignancies.
- Recent findings highlight that compounds like gallic acid and simvastatin can significantly improve the effectiveness of tyrosine kinase inhibitors and overcome treatment resistance by modulating metabolic pathways and drug transporters.
- The author's work also emphasizes the role of specific inhibitors, such as CDK4/6 inhibitors, in the treatment of cancers like estrogen receptor-positive breast cancer, showcasing advancements that improve patient outcomes when combined with standard therapies.